
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 644 | 81.1% | -1.41 | 242 | 37.6% |
| PLP(L) | 51 | 6.4% | 1.58 | 153 | 23.8% |
| SCL(L) | 43 | 5.4% | 1.74 | 144 | 22.4% |
| LH(L) | 24 | 3.0% | 0.50 | 34 | 5.3% |
| CentralBrain-unspecified | 8 | 1.0% | 1.95 | 31 | 4.8% |
| CA(L) | 2 | 0.3% | 3.25 | 19 | 3.0% |
| SLP(L) | 5 | 0.6% | 0.68 | 8 | 1.2% |
| ICL(L) | 4 | 0.5% | 1.00 | 8 | 1.2% |
| LAL(L) | 6 | 0.8% | -2.58 | 1 | 0.2% |
| GNG | 2 | 0.3% | 0.58 | 3 | 0.5% |
| IB | 3 | 0.4% | -inf | 0 | 0.0% |
| SAD | 2 | 0.3% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns M_l2PNm17 | % In | CV |
|---|---|---|---|---|---|
| l2LN23 (L) | 2 | GABA | 205 | 30.8% | 0.1 |
| M_l2PNm15 (L) | 1 | ACh | 50 | 7.5% | 0.0 |
| HRN_VP1d | 8 | ACh | 50 | 7.5% | 0.5 |
| v2LN4 (R) | 3 | ACh | 29 | 4.4% | 0.4 |
| ALIN3 (L) | 2 | ACh | 23 | 3.5% | 0.1 |
| VP5+Z_adPN (L) | 1 | ACh | 18 | 2.7% | 0.0 |
| HRN_VP4 | 9 | ACh | 18 | 2.7% | 0.5 |
| ALIN3 (R) | 2 | ACh | 15 | 2.3% | 0.2 |
| LAL173 (R) | 2 | ACh | 12 | 1.8% | 0.0 |
| lLN1_bc (L) | 9 | ACh | 12 | 1.8% | 0.5 |
| WEDPN2B_b (L) | 1 | GABA | 11 | 1.7% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 11 | 1.7% | 0.1 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 9 | 1.4% | 0.0 |
| TRN_VP3a | 3 | ACh | 9 | 1.4% | 0.7 |
| HRN_VP5 | 2 | ACh | 9 | 1.4% | 0.3 |
| VP4+VL1_l2PN (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| v2LN49 (L) | 2 | Glu | 8 | 1.2% | 0.2 |
| LHAV3p1 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 6 | 0.9% | 0.0 |
| vLN25 (L) | 2 | Glu | 5 | 0.8% | 0.6 |
| v2LNX01 (L) | 1 | unc | 4 | 0.6% | 0.0 |
| DA2_lPN (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| M_l2PNm14 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| lLN1_a (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| ALON3 (L) | 2 | Glu | 4 | 0.6% | 0.0 |
| CB3417 (L) | 4 | unc | 4 | 0.6% | 0.0 |
| SMP142 (L) | 1 | unc | 3 | 0.5% | 0.0 |
| WEDPN2B_a (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| WEDPN3 (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| v2LN30 (L) | 1 | unc | 3 | 0.5% | 0.0 |
| CB0650 (L) | 2 | Glu | 3 | 0.5% | 0.3 |
| M_lPNm11D (L) | 2 | ACh | 3 | 0.5% | 0.3 |
| lLN2R_a (L) | 2 | GABA | 3 | 0.5% | 0.3 |
| CL099 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP190 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PS098 (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| M_ilPNm90 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| v2LN38 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL234 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV6o1 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHPV7a2 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| vLN24 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| ALIN2 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| MZ_lv2PN (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| v2LN4 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| LHPV6k1 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| lLN2P_a (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 2 | 0.3% | 0.0 |
| TRN_VP2 | 1 | ACh | 1 | 0.2% | 0.0 |
| HRN_VP1l | 1 | ACh | 1 | 0.2% | 0.0 |
| CL362 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB4083 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP072 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| VP3+_l2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| LHPV1c2 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE074 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| v2LN42 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV6h3,SLP276 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB2185 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHPV5m1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP155 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3228 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_VPNml66 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB2151 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CL042 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| v2LN50 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_lPNm11A (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| v2LN32 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| vLN28 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD3c1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV5e1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| ALIN8 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP010 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| v2LN38 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3679 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP388 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| VP5+VP3_l2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| IB117 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| v2LN31 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| GNG087 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| lLN2X12 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP90b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP4+VL1_l2PN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_l2PNl21 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVC18 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| VL1_ilPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| DNb05 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns M_l2PNm17 | % Out | CV |
|---|---|---|---|---|---|
| CRE108 (L) | 1 | ACh | 88 | 8.7% | 0.0 |
| LHPV6f1 (L) | 5 | ACh | 85 | 8.4% | 0.2 |
| CL362 (L) | 1 | ACh | 59 | 5.9% | 0.0 |
| lLN1_bc (L) | 13 | ACh | 42 | 4.2% | 1.0 |
| SLP313 (L) | 2 | Glu | 40 | 4.0% | 0.3 |
| M_smPN6t2 (R) | 1 | GABA | 35 | 3.5% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 24 | 2.4% | 0.6 |
| l2LN23 (L) | 2 | GABA | 24 | 2.4% | 0.4 |
| LHPV5g2 (L) | 3 | ACh | 20 | 2.0% | 0.6 |
| M_lPNm11A (L) | 3 | ACh | 20 | 2.0% | 0.5 |
| LHPV2e1_a (L) | 2 | GABA | 19 | 1.9% | 0.2 |
| ALON3 (L) | 2 | Glu | 19 | 1.9% | 0.1 |
| v2LN34E (L) | 3 | Glu | 16 | 1.6% | 1.0 |
| SLP322 (L) | 3 | ACh | 16 | 1.6% | 0.4 |
| VP2+_adPN (L) | 1 | ACh | 15 | 1.5% | 0.0 |
| v2LN50 (L) | 3 | Glu | 14 | 1.4% | 0.1 |
| ALON1 (L) | 1 | ACh | 13 | 1.3% | 0.0 |
| CSD (R) | 1 | 5-HT | 13 | 1.3% | 0.0 |
| M_lPNm11A (R) | 3 | ACh | 13 | 1.3% | 0.4 |
| LHPV2c5 (L) | 1 | unc | 12 | 1.2% | 0.0 |
| LHPV7a2 (L) | 2 | ACh | 12 | 1.2% | 0.7 |
| lLN2X04 (L) | 2 | ACh | 12 | 1.2% | 0.5 |
| LHPV4c1_c (L) | 3 | Glu | 12 | 1.2% | 0.4 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 10 | 1.0% | 0.0 |
| M_lPNm13 (L) | 2 | ACh | 10 | 1.0% | 0.8 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 9 | 0.9% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 9 | 0.9% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 2 | ACh | 8 | 0.8% | 0.5 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 7 | 0.7% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 7 | 0.7% | 0.0 |
| v2LN34A (L) | 2 | Glu | 7 | 0.7% | 0.1 |
| PLP042a (L) | 1 | Glu | 6 | 0.6% | 0.0 |
| LHPV8a1 (L) | 1 | ACh | 6 | 0.6% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 6 | 0.6% | 0.0 |
| CB0650 (L) | 2 | Glu | 6 | 0.6% | 0.7 |
| CB1976 (L) | 1 | Glu | 5 | 0.5% | 0.0 |
| SMP142 (L) | 1 | unc | 5 | 0.5% | 0.0 |
| CL225 (L) | 1 | ACh | 5 | 0.5% | 0.0 |
| CB1300 (L) | 1 | ACh | 5 | 0.5% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 5 | 0.5% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 5 | 0.5% | 0.0 |
| LHPV2a1_a (L) | 2 | GABA | 5 | 0.5% | 0.6 |
| M_lvPNm48 (L) | 2 | ACh | 5 | 0.5% | 0.6 |
| LHPV6f5 (L) | 2 | ACh | 5 | 0.5% | 0.2 |
| M_lPNm11D (L) | 2 | ACh | 5 | 0.5% | 0.2 |
| OA-VUMa5 (M) | 2 | OA | 5 | 0.5% | 0.2 |
| LHAV3q1 (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| VP2_l2PN (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| VP4+VL1_l2PN (R) | 1 | ACh | 4 | 0.4% | 0.0 |
| VP4+VL1_l2PN (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| M_smPN6t2 (L) | 1 | GABA | 4 | 0.4% | 0.0 |
| DP1l_adPN (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| MZ_lv2PN (L) | 1 | GABA | 4 | 0.4% | 0.0 |
| LHPV5g1_b (L) | 2 | ACh | 4 | 0.4% | 0.5 |
| lLN13 (L) | 2 | GABA | 4 | 0.4% | 0.5 |
| lLN2P_c (L) | 2 | GABA | 4 | 0.4% | 0.5 |
| lLN2F_b (L) | 2 | GABA | 4 | 0.4% | 0.5 |
| LHPV6k1 (L) | 2 | Glu | 4 | 0.4% | 0.0 |
| SLP314 (L) | 4 | Glu | 4 | 0.4% | 0.0 |
| CB0683 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| SMP145 (R) | 1 | unc | 3 | 0.3% | 0.0 |
| VES091 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| v2LN4 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| SMP531 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| LHPV6o1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| SMP183 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| WED182 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| lLN1_a (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV6k2 (L) | 2 | Glu | 3 | 0.3% | 0.3 |
| LHAV7a5 (L) | 2 | Glu | 3 | 0.3% | 0.3 |
| CB4083 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| VES012 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SLP209 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| CB1171 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SMP208 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| l2LN22 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| LAL009 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAV7a6 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| SLP286 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| FB2F_c (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| CB3447 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV6h2 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| VES093_a (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| VM4_lvPN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SMP388 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| ALON2 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| GNG198 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| WEDPN10A (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP5+VP3_l2PN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| IB115 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| M_vPNml65 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| PLP257 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| M_l2PNl21 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| lLN2F_a (L) | 1 | unc | 2 | 0.2% | 0.0 |
| LHPV4c1_b (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| CB3417 (L) | 2 | unc | 2 | 0.2% | 0.0 |
| LHAV3o1 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| lLN2X12 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| HRN_VP1d | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN40_2 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| IB004_a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| lLN2T_c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| AVLP447 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP185 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP080 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP097 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| mAL5A2 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB2870 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP252 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV5b2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1500 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2937 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB2185 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CB3240 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP410 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6h1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP155 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV5h2_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN39a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| ATL020 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV3e2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL182 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV4c1_a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| lLN8 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPV8c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV4b7 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV2a3 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB3293 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP154 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_adPNm3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP239 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ALIN8 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP145 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VES001 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| l2LN20 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP382 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| WEDPN2A (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| ALIN3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2i2_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN33 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2d1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL008 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP2+VC5_l2PN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| WED092 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL150 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN2T_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VM4_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| M_l2PNm14 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL112 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| mAL4I (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| vLN25 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| M_imPNl92 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP206 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_spPN5t10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DA4m_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL1_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| il3LN6 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| AL-AST1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| V_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |